I have a protocol from Himes J Neuro-Onc 2020 using GBM EVs on peripheral blood monocytes. The endpoint is converting monocytes (CD14+ HDA-DR high) to MDSC (CD14+ HLA-DR low) with tumor derived EVs, and using these cells for functional studies. These cells are cultured w/o FBS, I am new in this field and wonder if not using FBS is routine in the field.
Thanks
Dominique